An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder

NCT02258828 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

FED

Sponsor class

Conditions

PTSD

Interventions

DRUG: Memantine
DRUG: Placebo

Sponsor

Sriram Ramaswamy

Collaborators

[object Object]